Rain Therapeutics Inc. Skyrocketed

Thu, Jun 23, 2022 at 08:30 PM

Rain Therapeutics Inc. (RAIN:NASDAQ) shot up at $3.44, a gain of 32.8%. On Thu, Jun 23, 2022, RAIN:NASDAQ hit a New 2-Week High of $3.44. The stock got featured on our News Catalysts scanner on Sun, Jun 05, 2022 at 09:16 AM in the 'INSIDER' category. From Fri, Jun 10, 2022, the stock recorded 75.00% Up Days and 44.44% Green Days

The stock spiked on Thu, Jun 23, 2022 at $4.39 with a volume of 4M+.

About Rain Therapeutics Inc. (RAIN:NASDAQ)

Rain Therapeutics Inc is a clinical-stage precision oncology company developing therapies that target oncogenic drivers for which they are able to genetically select patients they believe will most...

Top 10 Gainers:

Fujian Blue Hat Interactive Entertainment Technology Ltd. (BHAT:NASDAQ), 263.03%
RISE Education Cayman Ltd (REDU:NASDAQ), 138.46%
F-star Therapeutics Inc. (FSTX:NASDAQ), 59.8%
TDH Holdings, Inc. (PETZ:NASDAQ), 54.74%
Vroom Inc. (VRM:NASDAQ), 36.44%
Rain Therapeutics Inc. (RAIN:NASDAQ), 32.82%
Molecular Data Inc. (MKD:NASDAQ), 32.18%
Cardiff Oncology Inc. (CRDF:NASDAQ), 31.61%
22nd Century Group Inc (XXII:NASDAQ), 31.12%
9 Meters Biopharma, Inc. (NMTR:NASDAQ), 31.11%